Clinical and Experimental Studies on Recurrence and Metastasis of Hepatocellular Carcinoma-Progress and Prospect
Zhao‐You Tang
1997-01-01
Abstract:Hepatocellular carcinoma(HCC) has become the second cancer killer in China since 1990s, preventionand treatment of HCC are therefore urgently needed. In clinical aspect, surgery remains the best for a curativeoutcome of HCC, unfortunately, recurrence and metastasis are ma jor obstacles for further improve prognosis.Recently, studies on recurrence and metastasis have become attractive fields in all of the solid tumors, includingHCC. This paper has briefly reviewed the related literatures, with special reference to works done in author'sinstitution. In clinical aspect, re-resection has been proved to prolong survival further in patients with subclinical recurrence, however, prevention of recurrence is difficult, postoperative chemo/immuno/embolization mighthelp. In Experimental aspect, a highly metastatic human HCC model in nude mice has been established, invasiveness related molecular events (c - erb - B2, p16, p21, p53 , mdm2, VEGF ) TGFa, EGF receptor , MMP -2, ICAM - 1 were positively related, and nm23 - H1, TIMP -- 2, Integrin a5, Kai - 1 were negativelyrelated) have been studied, and intervention using antisense H --ras, antiHBx/antiCD3 bispecific antibody,gene therapies with TNF and TK genes, BB94 (matrix metalloproteinase inhibitor), TNP - 470 (anti-angio-genic), etc. have also been tried. It is expected that biotherapy, novel approach based on molecular findings,multidisciplinary interventions might be important, and anti-angiogenic approach will of particular implicationfor HCC.